Krsnaa Diagnostics Intrinsic Value
Krsnaa Diagnostics (KRSNAA) median intrinsic value is ₹551.88 from 9 valuation models (range ₹215–₹1077), vs current price ₹538.45 — +2.5% upside (Trading Near Calculated Value), margin of safety 2.4%. Also explore KRSNAA share price charts to track price trends across different timeframes.
KRSNAA Valuation Methods Summary — DCF, Graham Number & P/E
Krsnaa Diagnostics intrinsic value across 9 models vs current price ₹538.45 — upside/downside and value range per method. Browse KRSNAA financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹617.28 | ₹493.82 - ₹740.74 | +14.6% | EPS: ₹51.44, Sector P/E: 12x |
| Book Value Method | asset | ₹551.88 | ₹496.69 - ₹607.07 | +2.5% | Book Value/Share: ₹551.88, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹448.00 | ₹403.20 - ₹492.80 | -16.8% | Revenue/Share: ₹560.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1076.90 | ₹969.21 - ₹1184.59 | +100.0% | EBITDA: ₹344.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹215.38 | ₹172.30 - ₹258.46 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹329.22 | ₹296.30 - ₹362.14 | -38.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹423.87 | ₹381.48 - ₹466.26 | -21.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1076.90 | ₹969.21 - ₹1184.59 | +100.0% | ROE: 19.0%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹799.21 | ₹719.29 - ₹879.13 | +48.4% | EPS: ₹51.44, BVPS: ₹551.88 |
KRSNAA Intrinsic Value vs Market Price — All Valuation Models
Krsnaa Diagnostics fair value range ₹215–₹1077 vs current market price ₹538.45 across 9 valuation models. For current market price and key ratios, visit KRSNAA stock price BSE.
KRSNAA Intrinsic Value Analysis — Undervalued or Overvalued?
Krsnaa Diagnostics median intrinsic value ₹551.88, current price ₹538.45 — Trading Near Calculated Value by 2.5%, margin of safety 2.4%.
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹551.88 (median value). With the current market price of ₹538.45, this represents a +2.5% variance from our estimated fair value.
The valuation range spans from ₹215.38 to ₹1076.90, indicating ₹215.38 - ₹1076.90.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading near calculated value by approximately 2.5%.
KRSNAA Financial Health — Key Ratios vs Industry Benchmarks
Krsnaa Diagnostics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.46 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.70x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KRSNAA Cash Flow Quality — Operating & Free Cash Flow
Krsnaa Diagnostics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2017 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2016 | ₹-23 Cr | ₹-47 Cr | Negative Cash Flow | 3/10 |